Acorah Software Products - Accounts Production 19.2.450 false true true 31 December 2024 1 January 2024 false 1 January 2025 31 December 2025 31 December 2025 07881370 Dr Simon Bourne Mr Paul Gaudin Mrs Wendy Hall Dr David Pettigrew Mr Antony Walters Dr Thomas Wilkinson iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 07881370 2024-12-31 07881370 2025-12-31 07881370 2025-01-01 2025-12-31 07881370 frs-core:CurrentFinancialInstruments 2025-12-31 07881370 frs-core:Non-currentFinancialInstruments 2025-12-31 07881370 frs-core:ComputerEquipment 2025-12-31 07881370 frs-core:ComputerEquipment 2025-01-01 2025-12-31 07881370 frs-core:ComputerEquipment 2024-12-31 07881370 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-01-01 2025-12-31 07881370 frs-core:FurnitureFittings 2025-12-31 07881370 frs-core:FurnitureFittings 2025-01-01 2025-12-31 07881370 frs-core:FurnitureFittings 2024-12-31 07881370 frs-core:OtherResidualIntangibleAssets 2025-12-31 07881370 frs-core:OtherResidualIntangibleAssets 2025-01-01 2025-12-31 07881370 frs-core:OtherResidualIntangibleAssets 2024-12-31 07881370 frs-core:PlantMachinery 2025-12-31 07881370 frs-core:PlantMachinery 2025-01-01 2025-12-31 07881370 frs-core:PlantMachinery 2024-12-31 07881370 frs-core:SharePremium 2025-12-31 07881370 frs-core:ShareCapital 2025-12-31 07881370 frs-core:RetainedEarningsAccumulatedLosses 2025-12-31 07881370 frs-bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 07881370 frs-bus:FilletedAccounts 2025-01-01 2025-12-31 07881370 frs-bus:SmallEntities 2025-01-01 2025-12-31 07881370 frs-bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 07881370 frs-bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 07881370 frs-bus:OrdinaryShareClass1 2025-01-01 2025-12-31 07881370 frs-bus:OrdinaryShareClass1 2025-12-31 07881370 frs-bus:Director1 2025-01-01 2025-12-31 07881370 frs-bus:Director2 2025-01-01 2025-12-31 07881370 frs-bus:Director3 2025-01-01 2025-12-31 07881370 frs-bus:Director4 2025-01-01 2025-12-31 07881370 frs-bus:Director5 2025-01-01 2025-12-31 07881370 frs-bus:Director6 2025-01-01 2025-12-31 07881370 frs-countries:EnglandWales 2025-01-01 2025-12-31 07881370 2023-12-31 07881370 2024-12-31 07881370 2024-01-01 2024-12-31 07881370 frs-core:CurrentFinancialInstruments 2024-12-31 07881370 frs-core:Non-currentFinancialInstruments 2024-12-31 07881370 frs-core:SharePremium 2024-12-31 07881370 frs-core:ShareCapital 2024-12-31 07881370 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31 07881370 frs-bus:OrdinaryShareClass1 2024-01-01 2024-12-31 07881370 frs-core:CurrentFinancialInstruments 1 2024-12-31
Registered number: 07881370
my mhealth Limited
Unaudited Financial Statements
For The Year Ended 31 December 2025
my mhealth Limited
Contents
Contents

| Page
--- | ---
Balance Sheet | 1—2
Notes to the Financial Statements | 3—6

Page 1
my mhealth Limited
Balance Sheet
As At 31 December 2025
Balance Sheet
Registered number: 07881370

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
FIXED ASSETS
Intangible Assets | 4 |  | 579,205 |  | 585,506
Tangible Assets | 5 |  | 37,120 |  | 48,967
|  |  | 616,325 |  | 634,473
CURRENT ASSETS
Debtors | 6 | 1,851,820 |  | 1,664,754 |
Cash at bank and in hand |  | 46,614 |  | 78,711 |
|  | 1,898,434 |  | 1,743,465 |
Creditors: Amounts Falling Due Within One Year | 7 | (1,923,428 ) |  | (1,461,442 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | (24,994 ) |  | 282,023
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 591,331 |  | 916,496
NET ASSETS |  |  | 591,331 |  | 916,496
CAPITAL AND RESERVES
Called up share capital | 8 |  | 606 |  | 605
Share premium account |  |  | 3,039,232 |  | 3,007,173
Profit and Loss Account |  |  | (2,448,507 ) |  | (2,091,282 )
SHAREHOLDERS' FUNDS |  |  | 591,331 |  | 916,496

Page 1
Page 2
my mhealth Limited
Balance Sheet (continued)
As At 31 December 2025
For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Dr David Pettigrew Director
02/06/2026

The notes on pages 3 to 6 form part of these financial statements.
Page 2
Page 3
my mhealth Limited
Notes to the Financial Statements
For The Year Ended 31 December 2025
Notes to the Financial Statements
1. General Information
my mhealth Limited is a private company, limited by shares, incorporated in England & Wales, registered number 07881370 . The registered office is 41 Lothbury, London, EC2R 7HF.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Going Concern Disclosure
The directors have prepared these financial statements on a going concern basis. In reaching this conclusion, the directors have considered the financial position of the company and its future prospects for a period of not less than twelve months from the date of approval of these financial statements.
The company continues to generate recurring revenues with turnover of £1,646,194 for the year ended 31 December 2025 (2024: £1,710,276). The company has reported a loss after taxation of £357,225 (2024: £644,651), reflecting continued investment in product development and commercial infrastructure. As at 31 December 2025, the company had net assets of £591,331 (2024: £916,496).
The directors acknowledge that the company's operational cash requirements are currently in excess of revenues generated, and that this represents a material uncertainty which may cast significant doubt upon the company's ability to continue as a going concern. However, the directors are confident that this can be managed through a combination of:
• continued growth in contracted recurring revenues;
• active management of operating costs;
• existing shareholder and director support; and
• access to additional funding as required.
After making enquiries and reviewing cash flow forecasts, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future.
Subsequent to the year end, the company received a loan of £250,000 from a third-party lender in January 2026, providing further support to near-term working capital requirements. Accordingly, the directors continue to adopt the going concern basis in preparing the financial statements.
2.3. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.4. Intangible Fixed Assets and Amortisation - Other Intangible
Other intangible assets relates to the development of software. It is amortised to profit and loss account over its estimated economic life of 3 years.
Page 3
Page 4
my mhealth Limited
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2025
2.5. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Plant & Machinery | 25% on reducing balance
Fixtures & Fittings | 25% on reducing balance
Computer Equipment | 25% on reducing balance

2.6. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and asset reflects the tax consequences that would follow from the manner in which the company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
2.7. Government Grant
Government grants are recognised in the profit and loss account in an appropriate manner that matches them with the expenditure towards which they are intended to contribute.
Grants for immediate financial support or to cover costs already incurred are recognised immediately in the profit and loss account. Grants towards general activities of the entity over a specific period are recognised in the profit and loss account over that period.
Grants towards fixed assets are recognised over the expected useful lives of the related assets and are treated as deferred income and released to the profit and loss account over the useful life of the asset concerned.
All grants in the profit and loss account are recognised when all conditions for receipt have been complied with.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 28 (2024: 31)
28 31
Page 4
Page 5
my mhealth Limited
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2025
4. Intangible Assets

| Other
--- | ---
| £
Cost
As at 1 January 2025 | 1,545,365
Additions | 383,863
As at 31 December 2025 | 1,929,228
Amortisation
As at 1 January 2025 | 959,859
Provided during the period | 390,164
As at 31 December 2025 | 1,350,023
Net Book Value
As at 31 December 2025 | 579,205
As at 1 January 2025 | 585,506

5. Tangible Assets

| Plant & Machinery | Fixtures & Fittings | Computer Equipment | Total
--- | --- | --- | --- | ---
| £ | £ | £ | £
Cost
As at 1 January 2025 | 130,245 | 4,140 | 104,194 | 238,579
Additions | 374 | - | 77 | 451
As at 31 December 2025 | 130,619 | 4,140 | 104,271 | 239,030
Depreciation
As at 1 January 2025 | 107,413 | 2,994 | 79,205 | 189,612
Provided during the period | 5,762 | 286 | 6,250 | 12,298
As at 31 December 2025 | 113,175 | 3,280 | 85,455 | 201,910
Net Book Value
As at 31 December 2025 | 17,444 | 860 | 18,816 | 37,120
As at 1 January 2025 | 22,832 | 1,146 | 24,989 | 48,967

6. Debtors

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Due within one year
Trade debtors | 94,800 |  | 272,773
Prepayments and accrued income | 409,325 |  | 235,721
Other debtor | - |  | 3,944
Corporation tax recoverable assets | 101,615 |  | 123,165
Amounts owed by group undertakings | 237,545 |  | 794
| 843,285 |  | 636,397

...CONTINUED
Page 5
Page 6
my mhealth Limited
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2025

Due after more than one year
Deferred tax asset | 1,008,535 |  | 1,028,357
| 1,851,820 |  | 1,664,754

7. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Trade creditors | 70,007 |  | 125,243
Other loans | 222,500 |  | 100,000
Other taxes and social security | 81,879 |  | 172,710
VAT | 261,084 |  | 103,401
Other creditors | 9,180 |  | 9,410
Accruals and deferred income | 1,094,644 |  | 766,544
Directors' loan accounts | 184,134 |  | 184,134
| 1,923,428 |  | 1,461,442

8. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
Allotted, called up and fully paid | £ |  | £
606,824 Ordinary Shares of £ 0.001 each | 606 |  | 605

Page 6